|
Melanoma Research Studies
ADJUVANT
E1697 Phase
III Randomized Study of Four Weeks High Dose IFN-a2b in Stage T2b
N0,
T3a-b,
T4a-b
N0,
and T1-4
N1a ,2a, 3 (microscopic) Melanoma
METASTATIC
N0675 A
Phase II Study of Temozolomide and Everolimus (RAD-001) Therapy for Metastatic
Melanoma
S0438 A
Randomized Phase II Trial of BAY 43-9006 (Sorafenib) with Either CCI-779
(Temsirolimus) or R115777 (Tipifarnib) in Metastatic Melanoma
DESMOPLASTIC
N0275 Phase II Trial
Evaluating Resection Followed by Adjuvant Radiation Therapy for Patients with
Desmoplastic Melanoma
|